Return to:

Delivery Models

View 8 related solutions for PAREXEL® BioPharm Unit


PAREXEL® BioPharm Unit

If it’s important to you, it’s important to us.

From one life-changing molecule to the next wonder of modern medicine, PAREXEL® is committed to working with small and mid-size companies.  We believe one of the most valuable aspects you can offer any client is absolute dedication.  That’s why we’ve created the PAREXEL BioPharm Unit– a dedicated group focused solely on the unique needs of small and mid-size companies.  This means for every drug, treatment, and molecule we work on, we assign an employee team that delivers innovative, tailored solutions for every one of our clients – every time.  Some may call this commitment. Here at PAREXEL, we like to think of it as a bond with our clients in achieving their development goals. We think this bond is a critical component of the success of any project we undertake. 

Your company always deserves our best.

Small and mid-size companies are the genesis of innovation, with recent data indicating that 81% of ongoing development programs originated outside of the top 25 pharmaceutical companies.  To help bring success to companies like yours, we adhere firmly to the highest standards, operational excellence, and to the best practices in the industry.  At PAREXEL, we understand what’s important to our small and mid-size clients and that’s why the PAREXEL BioPharm Unit emphasizes:

• Dedicated teams – We provide a senior management leader and a dedicated team who are personally committed to your success. This team will work closely with you, providing ongoing, frequent communication and proactive solutions. You will feel a true sense of project ownership and collaboration.

• Innovative and effective study execution – Having a dedicated team, combined with streamlined protocols and integrated technology, increases the speed of study start-up, shortens database lock, and improves overall efficiency.

• Aligned incentives –In drug development, the stakes are high – especially if you’re vested in a small number of drugs. That’s why we hold ourselves accountable for delivery and quality. Confidence in our execution equates to alignment of incentives in meeting your critical development milestones.


Our expertise and global reach is at your disposal.

Armed with a broad array of in-house MDs and PhDs, PAREXEL has therapeutic experts who work closely with you to ensure your company gets the most relevant and effective strategies needed to help you achieve your critical development goals.

Spanning a range of therapeutic areas, our expertise includes oncology, immunology and CNS, cardiovascular, metabolic, and infectious disease, and offers broad study experience and direct knowledge of study requirements, risk management, and best practice implementation.

With 81 locations in 51 countries around the world, PAREXEL is proud to provide high quality clinical research.

Designing the right model to accomplish your goals.

At PAREXEL, we know that no two projects are ever the same. That’s why we work closely with every client to determine the very best model, and then tailor that model to meet the specific needs of each company. By creating a true sense of project ownership and collaboration, we act as your partners, where our success is only measured by yours. 

From delivering smarter solutions to anticipating your specific needs, we truly believe the people you choose to work with make all the difference. When you choose PAREXEL, you not only get 100% dedication to every project, every time, you also get a partner who is focused on the most important thing of all – your success.

Key Materials

PAREXEL Creates Customized Biopharm Unit

Q&A with Ubavka DeNoble, M.D. about small and mid-size company needs

Read about PAREXEL's Ubavka DeNoble’s Q+A with Contract Pharma on small/mid-sized biopharm needs. Click here.  

Explore PAREXEL® BioPharm Unit
All Solutions
All Solutions
Clinical Research

View More...

Early Phase Services

More of What You Need for a Stronger Start in Phase I. Your journey from new molecule to new medicine starts with appropriate subjects, world class facilities, and more timely results. PAREXEL® provides comprehensive early phase testing services through our own hospital-based clinical units on three continents.

read more

Peri/Post-Approval Services

More Tools to Simplify Your Journey Before and After Approval When it’s time to shift your development journey toward commercialization to gain first market access, PAREXEL® is the partner to help you do it…seamlessly, securely, and cost-effectively.

read more

Clinical Trial Supplies & Logistics

Clinical Trials Are Now More Complex, But Your Journey Shouldn’t Be You need to test your new medicine in key markets worldwide, but organizing consistent delivery of your trial-related supplies to multiple locations is complicated. PAREXEL® offers smart tools for managing your clinical trial logistics.

read more

Phase II-III Services

Improving Your Journey by Improving Every Step of Your Clinical Trials. During the part of your journey from Proof-of-Concept through regulatory submission, PAREXEL® Phase II-III specialists optimize every step of your clinical trials by every means possible.

read more

Strategic Compliance & Risk Management

Our trusted experts, including renowned former regulators, know how to institute proactive compliance and have a strong track record of helping companies get out of regulatory crises. They are well versed in biopharmaceutical, medical device / diagnostic regulations and ICH guidance, and are focused on the success of your products and company.

read more

Integrated Product Development

Journeys, of course, have varied destinations. But whether you’re taking a new molecule to market, exploring how to differentiate a current product, or evaluating new geographic options, PAREXEL®’s Integrated Product Development team can shorten your product’s time to market and provide the strategic bandwidth and marketplace resources to help that product achieve more commercially.

read more

HERON™ Commercialization

In this post-blockbuster era, traditional opportunities for sustained growth throughout your products’ long-term journey are limited. Biologics, biomarkers, genomics, personalized medicine, and proteomics offer promising alternatives, but commercial dynamics of the biopharmaceutical industry are uncertain.

read more

Medical Communications

Successful commercialization is no longer just about gaining regulatory approval. It is about meeting the needs of a growing number of stakeholders, including physicians, patients, governments and payers. Success requires integrated pharmaceutical teamwork, including the right Medical Communications expertise where needed, to address the traditional silos of R&D, marketing and regulatory and focus on the same goals.

read more